Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression
- PMID: 1697411
Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression
Abstract
C-myc gene down-regulation is known to be mediated by a transcriptional block at the end of exon-1 (Bentley & Groudine, 1986; Siebenlist et al., 1988). When transcription is initiated normally, this block is expected to produce a truncated RNA, but to date, this product has escaped direct detection in somatic cells. We have been able to detect a 0.38 kb c-myc exon-1 specific RNA species by northern blot analysis. This RNA appeared not only in dimethyl sulfoxide (DMSO)-induced HL-60 cells, but also in uninduced HL-60 cells, the NALM-6, REH, RPMI-8392 and TALL-1 cell lines, and in human T-cell acute lymphocytic leukemia (T-ALL) and normal peripheral blood lymphocytes (PBL), indicating that the transcriptional block producing it is constitutive. In HL-60 cells, the 0.38 kb RNA level increased on DMSO induction while the 2.3 kb c-myc mRNA was down-regulated. Upon DMSO removal, as the 2.3 kb mRNA was made again, the 0.38 kb RNA fell to preinduction levels, Thus, modulation of this constitutive block regulates the relative amounts of c-myc message available for translation in response to specific growth stimuli. This mechanism for c-myc gene regulation may be common within the hematologic system.
Similar articles
-
The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.Oncogene. 1988 Oct;3(4):397-403. Oncogene. 1988. PMID: 3078949
-
DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.Oncogene. 1989 Feb;4(2):175-9. Oncogene. 1989. PMID: 2648255
-
Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.Oncogene. 1992 Sep;7(9):1817-25. Oncogene. 1992. PMID: 1323820
-
Transcriptional down-regulation of c-myc expression by protein synthesis-dependent and -independent pathways in a human T lymphoblastic tumor cell line.Cell Growth Differ. 1990 Mar;1(3):113-7. Cell Growth Differ. 1990. PMID: 2127692
-
The regulatory strategies of c-myc and c-fos proto-oncogenes share some common mechanisms.Biochimie. 1988 Jul;70(7):877-84. doi: 10.1016/0300-9084(88)90228-3. Biochimie. 1988. PMID: 3145022 Review.
Cited by
-
Sequence requirements for premature transcription arrest within the first intron of the mouse c-fos gene.Mol Cell Biol. 1991 May;11(5):2832-41. doi: 10.1128/mcb.11.5.2832-2841.1991. Mol Cell Biol. 1991. PMID: 1901950 Free PMC article.
-
Control of formation of two distinct classes of RNA polymerase II elongation complexes.Mol Cell Biol. 1992 May;12(5):2078-90. doi: 10.1128/mcb.12.5.2078-2090.1992. Mol Cell Biol. 1992. PMID: 1569941 Free PMC article.
-
Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line.Am J Pathol. 1994 May;144(5):1023-34. Am J Pathol. 1994. PMID: 8178926 Free PMC article.
-
Analysis of premature termination in c-myc during transcription by RNA polymerase II in a HeLa nuclear extract.Mol Cell Biol. 1991 Sep;11(9):4599-615. doi: 10.1128/mcb.11.9.4599-4615.1991. Mol Cell Biol. 1991. PMID: 1715021 Free PMC article.
-
Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo.EMBO J. 1992 Sep;11(9):3307-14. doi: 10.1002/j.1460-2075.1992.tb05409.x. EMBO J. 1992. PMID: 1505520 Free PMC article.